查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2014261

基因改造作物農業生物技術市場：按性狀類型、作物類型、應用和最終用戶分類的全球市場預測 – 2026–2032

Agricultural Biotechnology for Transgenic Crops Market by Trait Type, Crop Type, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，基改作物的農業生物技術市場價值將達到 13.1 億美元，到 2026 年將成長到 14.2 億美元，到 2032 年將達到 23.8 億美元，複合年成長率為 8.89%。

主要市場統計數據
基準年 2025 13.1億美元
預計年份：2026年 14.2億美元
預測年份 2032 23.8億美元
複合年成長率 (%) 8.89%

以技術進步、監管變革和農業價值鏈各相關人員的期望為驅動力，制定了引入基因改造作物的策略框架。

隨著基因改造作物從利基創新發展成為韌性農業食品系統的核心組成部分，農業生物技術格局正在經歷決定性的變革。表現型工程的進步，加上不斷完善的法規結構和不斷變化的市場動態，正在重塑從種子研發者到農民和政策制定者等相關人員改良作物的方式。本文首先概述了影響基改作物發展的多面向因素，然後將後續分析置於研究流程、供應鏈整合和市場接受度等現實背景中進行探討。

快速的技術創新、不斷發展的法規結構和不斷變化的商業性重點如何重新定義基改作物開發中的價值創造和競爭地位。

基因改造作物的格局正在發生變化，改變了競爭動態、投資重點和推廣路徑。基因編輯、性狀疊加和高通量表現型分析等技術的進步，加速了可操作性狀從概念到田間試驗的轉化。因此，那些整合分子層級創新、可操作育種策略和可靠田間檢驗的公司正在獲得策略優勢。同時，種子企業營運的日益成熟也為這種技術發展動能提供了助力。如今，種子企業正將獨特的性狀與改良的種子處理方法和數位化農業技術相結合，從而在田間展現出切實可見的價值。

到 2025 年，了解關稅政策變化對基因改造作物供應鏈、研究合作和農場決策的廣泛商業性和營運連鎖反應。

到2025年，已宣布並實施的關稅政策變化所帶來的累積影響，正在造成供應商和買家都無法忽視的商業性複雜性。關稅調整會影響整個國際供應鏈中農產品、種子和性狀許可交易的成本計算。對於跨國開發商而言，關稅波動會使生產基地選址、田間試驗地點和庫存儲存地點等決策變得更加複雜，同時也會影響其在出口導向作物領域保持競爭力所需的定價策略。

利用性狀作物應用和最終用戶細分之間的細微差別，協調基因改造作物舉措中的研究重點、商業化策略和相關人員參與。

有效的細分主導方法揭示了技術進步與商業性需求的交會點，從而創造了差異化的機會。基於性狀類型，重點集中在耐旱性、耐除草劑性和抗蟲性上，因為這些是推動技術快速應用的關鍵因素。每種性狀都具有獨特的農業化學品優勢，並影響育種重點。基於作物類型，菜籽、棉花、玉米和大豆代表了作物特有的發展路徑，它們在性狀價值提案、監管路徑和種子系統動態存在顯著差異。策略規劃必須反映這些作物特有的實際情況。基於應用領域，生質燃料、食品和飼料、藥品以及加工應用定義了終端市場需求和品質標準，這些標準影響性狀選擇、管理責任預期和可追溯性需求。基於最終用戶，生態系統由生物技術公司、農民、政府機構、研究機構和種子企業組成，每個群體都對商業化時間表、責任和推廣獎勵施加獨特的壓力。

了解美洲、歐洲、中東和非洲以及亞太地區的獨特區域機會和監管現實，並最佳化性狀開發和打入市場策略。

區域趨勢在塑造基因改造作物推廣應用軌跡和行業相關人員的商業選擇方面發揮著至關重要的作用。在美洲，一體化的價值鏈、強大的私營部門育種能力以及農民對基因工程技術的廣泛了解，為快速迭代開發和商業化規模化生產創造了有利條件。這種環境鼓勵進行性狀疊加試驗，並使商業業者能夠在不同的農業生態區域檢驗農業化學品的功效。

本研究檢驗了綜合研發和管理夥伴關係以及卓越營運如何決定基因改造作物開發生態系統中的競爭優勢。

基因改造作物領域的競爭動態是由科學能力、監管專業知識和商業性執行力三者共同驅動的。領先企業透過管理整個創新生命週期脫穎而出，涵蓋從發現和分子層級表徵到多點田間檢驗、監管申報和商業種子繁殖的各個環節。夥伴關係、授權和收購仍是拓展性狀組合和加速產品上市速度的重要手段。

為實現基因改造作物的可擴展和負責任的引進，需要採取必要的策略步驟，協調性狀開發、監管準備、供應鏈韌性和管理工作。

產業領導者應採取一系列切實可行的措施，將科學潛力轉化為商業性韌性和社會價值。首先，性狀開發藍圖應與特定作物的農業化學品實際情況和終端市場需求相符，優先考慮那些即使在氣候變遷下也能帶來可衡量的農場效益和韌性的性狀。其次，應制定監管策略，透過投資模組化資料包、適應性試驗設計以及與監管機構和民間社會相關人員的積極互動，來應對不同司法管轄區的差異。

為了根據嚴謹的證據得出結論，我們採用了調查方法，結合了對專家的直接訪談、二手文獻、監管審查和價值鏈分析。

本研究整合了同儕審查的科學文獻、監管文件、公共文件以及與專家相關人員的定性訪談，建構了一個穩健且具說服力的分析基礎。調查方法強調跨多個資料來源進行三角驗證，並透過專家諮詢檢驗，以確保解釋既反映技術現實，又兼顧商業性限制。研究還仔細審查了田間試驗報告、專利趨勢和科學會議報告，以評估關鍵性狀類別的成熟度並識別新興技術能力。

採取綜合方法，將科學創新、監管合規、管理和相關人員參與相結合，以負責任的方式實現基因改造作物的潛力。

總而言之，基改作物技術正處於策略轉折點，科學能力、監管進步和商業性需求在此交會。未來的發展路徑需要一項綜合策略，將性狀創新與作物的具體實際情況、應用需求和最終用戶期望相結合。雖然技術進步降低了開發高價值性狀的技術壁壘，但由於管理體制的多樣性和近期貿易政策的變化，商業環境變得更加複雜，因此制定符合實際情況的商業化藍圖至關重要。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：基改作物農業生物技術市場－依性狀類型分類

  • 抗乾燥性
  • 除草劑抗性
  • 抗蟲害

第9章：基改作物農業生物技術市場：依作物類型分類

  • 菜籽
  • 棉布
  • 玉米
  • 大豆

第10章：基改作物農業生技市場：依應用領域分類

  • 生質燃料
  • 食品/飼料
  • 製藥
  • 加工

第11章：基改作物農業生技市場：依最終用戶分類

  • 生技公司
  • 農民
  • 政府機構
  • 研究機構
  • 種子企業

第12章 基因改造作物農業生物技術市場：按地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章：基改作物農業生技市場：依類別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 基因改造作物農業生物技術市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國基改作物農業生物技術市場

第16章：中國基改作物農業生技市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Arcadia Biosciences, Inc.
  • BASF SE
  • Bayer AG
  • Bioceres Crop Solutions Corp
  • Calyxt Inc.
  • Corteva, Inc.
  • Evogene Ltd
  • Groupe Limagrain
  • JR Simplot Co.
  • JK Agri Genetics Ltd.
  • KWS SAAT SE & Co. KGaA
  • Land O'Lakes, Inc.
  • Maharashtra Hybrid Seed Company
  • Nuseed Pty Ltd
  • Sakata Seed Corporation
  • Syngenta AG
  • UPL Limited
Product Code: MRR-433AB1DC2851

The Agricultural Biotechnology for Transgenic Crops Market was valued at USD 1.31 billion in 2025 and is projected to grow to USD 1.42 billion in 2026, with a CAGR of 8.89%, reaching USD 2.38 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.31 billion
Estimated Year [2026] USD 1.42 billion
Forecast Year [2032] USD 2.38 billion
CAGR (%) 8.89%

Framing the strategic context for transgenic crop deployment amid technological advances regulatory shifts and stakeholder expectations across agricultural value chains

The agricultural biotechnology landscape is undergoing a pivotal transformation as transgenic crops move from niche innovations to core components of resilient agrifood systems. Advances in trait engineering, combined with evolving regulatory frameworks and shifting trade dynamics, are reshaping how stakeholders - from seed developers to farmers and policy makers - approach crop improvement. This introduction frames the multidimensional forces influencing transgenic crop development, situating the subsequent analysis within the practical realities of research pipelines, supply chain integration, and market acceptance.

Over the past decade, precision breeding techniques and improved trait stacking have increased both the technical feasibility and the commercial attractiveness of transgenic solutions targeting drought tolerance, herbicide tolerance, and insect resistance. At the same time, end-user demands for stable yields, reduced input costs, and environmental risk mitigation have sharpened the focus on traits that deliver clear agronomic and economic benefits. Consequently, organizations across the value chain are recalibrating priorities, aligning R&D investments with traits that demonstrate field-proven outcomes.

This report opens by outlining the strategic context for transgenic crop deployment and the operational implications for key stakeholders. By synthesizing scientific trends, regulatory signals, and market behaviors, the introduction prepares readers to interpret the deeper analyses that follow and to identify strategic inflection points where investment and policy choices will matter most.

How rapid technological innovation evolving regulatory frameworks and shifting commercial priorities are redefining value creation and competitive positioning in transgenic crop development

The landscape for transgenic crops is shifting in ways that alter competitive dynamics, investment priorities, and adoption pathways. Technological progress in gene editing, trait stacking, and high-throughput phenotyping has accelerated the pace at which actionable traits move from concept to field trials. As a result, companies that integrate molecular innovation with pragmatic breeding strategies and robust field validation are gaining a strategic edge. This technological momentum is complemented by growing operational sophistication among seed companies, which are increasingly combining proprietary traits with enhanced seed treatments and digital agronomy to deliver demonstrable on-farm value.

Simultaneously, regulatory frameworks are evolving to accommodate novel biotechnologies while balancing public acceptance and biosafety concerns. In several jurisdictions, streamlined approval pathways for certain gene-edited events have reduced time to commercialization, prompting a reconsideration of global development strategies. That said, regulatory heterogeneity persists, and firms must design compliant, flexible product portfolios that address divergent approval requirements across key markets.

Market acceptance is also changing as downstream actors-processors, food and feed companies, and farmers-assess the economic and sustainability implications of transgenic adoption. Increasing emphasis on resilience has elevated the importance of traits like drought tolerance, while integrated pest management priorities continue to support insect resistance innovations. Taken together, these transformative shifts are redefining where value is created and captured within the transgenic ecosystem, underscoring the need for cross-functional strategies that bridge science, regulatory affairs, and commercial execution.

Understanding the broad commercial and operational ripple effects of tariff policy changes on transgenic crop supply chains research collaborations and on-farm decision making through 2025

The cumulative effect of tariff policy changes announced and implemented through 2025 has introduced a layer of commercial complexity that suppliers and buyers cannot ignore. Tariff adjustments influence the cost calculus for traded agricultural commodities, seed inputs, and trait licensing across international supply chains. For multinational developers, tariff volatility complicates decisions about where to stage production, conduct field trials, and place inventory, and it affects the pricing strategies necessary to maintain competitiveness in export-focused crop segments.

Trade frictions also have indirect consequences for research and development collaborations. When cross-border exchanges of germplasm, biological materials, or specialized equipment become more expensive or administratively burdensome, project timelines extend and transactional friction increases. In that context, companies are recalibrating partnership models by emphasizing regional hubs for breeding and scaling operations, thereby reducing exposure to tariff-driven cost shocks while preserving access to critical germplasm pools.

From a farmer and processor perspective, tariff-driven changes to input and commodity economics can shift crop rotations and management choices, thereby influencing trait demand. For example, altered import or export incentives for maize, soybean, cotton, or canola change growers' risk-reward calculations and can accelerate or delay adoption of specific transgenic traits. Policymakers and industry leaders must therefore account for both direct tariff impacts and the cascade of behavioral responses that reshape deployment patterns across geographies.

Leveraging nuanced trait crop application and end user segmentation to align research priorities commercialization strategies and stakeholder engagement for transgenic crop initiatives

An effective segmentation-driven approach illuminates where technological advances and commercial demand intersect to create differentiated opportunities. Based on Trait Type, attention centers on Drought Tolerance, Herbicide Tolerance, and Insect Resistance as primary vectors for near-term adoption, each delivering distinct agronomic benefits and influencing breeding priorities. Based on Crop Type, Canola, Cotton, Maize, and Soybean represent crop-specific pathways where trait value propositions, regulatory pathways, and seed system dynamics vary markedly; strategic plans must reflect those crop-specific realities. Based on Application, Biofuel, Food & Feed, Pharmaceutical, and Processing uses define end-market requirements and quality thresholds that shape trait selection, stewardship expectations, and traceability needs. Based on End User, the ecosystem comprises Biotech Companies, Farmers, Government Bodies, Research Institutions, and Seed Companies, each of which exerts unique pressures on commercialization timelines, liability profiles, and adoption incentives.

Interpreting segmentation through a strategic lens reveals that trait-centric investment should align closely with crop economics and application needs. Drought tolerance commands strategic importance where climate variability threatens yield stability, while herbicide tolerance and insect resistance continue to underpin operational efficiencies and pest management strategies. Crop-specific constraints and processing requirements mean that a one-size-fits-all approach to trait development is unlikely to produce sustainable returns. Instead, integrated programs that couple trait innovation with seed performance, stewardship frameworks, and supply chain assurances will unlock broader acceptance.

Moreover, end-user diversity underscores the necessity of cross-sector engagement. Successful deployment depends on engaging farmers to validate agronomic benefits in real-world settings, coordinating with seed companies on distribution and stewardship, partnering with research institutions on long-term trait improvement, and working with government bodies to ensure regulatory alignment and public confidence. By grounding R&D and commercialization plans in these layered segmentation insights, organizations can better allocate resources and tailor messages to the stakeholders most critical to adoption.

Navigating distinct regional opportunities and regulatory realities across the Americas Europe Middle East & Africa and Asia-Pacific to optimize trait development and market entry strategies

Regional dynamics play a decisive role in shaping the trajectory of transgenic crop deployment and the operational choices of industry participants. In the Americas, integrated value chains, significant private-sector breeding capacity, and widespread farmer familiarity with transgenic technologies create fertile conditions for rapid iteration and commercial scaling. This environment supports experimentation with trait stacks and enables commercial entities to validate agronomic claims across diverse agroecological zones.

Europe, Middle East & Africa present a more complex regulatory and social landscape where public perception, diverse regulatory approaches, and heterogeneous infrastructure levels drive differentiated strategies. In some jurisdictions within this region, stringent regulatory requirements and heightened stakeholder scrutiny necessitate a cautious, transparency-focused approach. Meanwhile, parts of Africa and the Middle East represent strategic opportunities for traits that address climate resilience and resource constraints, provided developers invest in public engagement and capacity building.

Asia-Pacific encompasses a broad spectrum of adoption scenarios, from highly commercialized cropping systems to smallholder-dominated landscapes. Regulatory environments and consumer preferences vary widely, influencing product acceptance, stewardship models, and partnership structures. Companies operating in this region increasingly pursue localized breeding programs and public-private partnerships to ensure that transgenic traits address both large-scale commodity demands and localized crop challenges. Across all regions, success depends on tailoring strategies to regulatory realities, supply chain structures, and stakeholder expectations in each geography.

Examining how integrated R&D stewardship partnerships and operational excellence determine competitive advantage in the transgenic crop development ecosystem

Competitive dynamics within the transgenic crop arena are driven by a combination of scientific capability, regulatory expertise, and commercial execution. Leading organizations differentiate themselves by managing the entire innovation lifecycle: from discovery and molecular characterization to multi-location field validation, regulatory submission, and commercial seed multiplication. Partnerships, licensing arrangements, and acquisitions remain important levers for expanding trait portfolios and accelerating time-to-market.

In addition to proprietary trait development, successful companies demonstrate strength in stewardship and supply chain reliability. They invest in data-driven agronomy services, farmer training programs, and post-commercialization monitoring to preserve trait efficacy and manage resistance risks. Firms that integrate molecular R&D with practical extension and commercial support are better positioned to achieve durable adoption and mitigate reputational and regulatory risks.

Research institutions and public sector actors continue to play a critical role, particularly in early-stage discovery and in contexts where public goods such as drought tolerance for smallholder systems are prioritized. Collaborative models that combine private-sector scale with public-sector legitimacy can accelerate adoption while addressing societal concerns. Overall, the competitive landscape rewards vertically integrated capabilities, collaborative agility, and a disciplined approach to regulatory and stewardship obligations.

Mandated strategic actions to synchronize trait development regulatory preparedness supply chain resilience and stewardship efforts for scalable responsible adoption of transgenic crops

Industry leaders should adopt a set of practical actions to translate scientific promise into commercial resilience and societal value. First, align trait development roadmaps with crop-specific agronomic realities and end-market requirements, prioritizing traits that deliver measurable on-farm benefits and resilience under climate variability. Second, build regulatory strategies that anticipate heterogeneity across jurisdictions by investing in modular data packages, adaptive trial designs, and proactive engagement with regulators and civil society stakeholders.

Third, strengthen supply chain resilience by establishing regional breeding hubs, local seed multiplication capacity, and redundant logistics to mitigate tariff or trade disruptions. Fourth, commit to robust stewardship programs that combine resistance management, farmer training, and post-market surveillance to maintain trait efficacy and public trust. Fifth, pursue collaborative models that leverage public research strengths alongside private-sector commercialization capacity to address challenges in smallholder contexts and to broaden social legitimacy.

Finally, invest in transparent communication strategies that articulate the agronomic, environmental, and economic rationale for transgenic solutions while openly addressing safety and stewardship concerns. By executing these actions in concert, leaders can reduce commercialization friction, accelerate adoption where appropriate, and align transgenic crop innovations with broader sustainability and food security goals.

Methodological approach that integrates primary expert interviews secondary literature regulatory review and value chain analysis to ensure rigorous evidence-based conclusions

This research synthesizes peer-reviewed scientific literature, regulatory filings, public policy documents, and primary qualitative interviews with expert stakeholders to construct a robust and defensible analytical foundation. The methodology emphasizes triangulation across multiple data sources and validation through expert consultation to ensure that interpretations reflect both technological realities and commercial constraints. Field trial reports, patent landscapes, and scientific conference disclosures were reviewed to assess the maturity of key trait categories and to identify emergent technical capabilities.

Primary research included structured interviews with senior R&D leaders, regulatory specialists, seed company executives, and academic researchers to capture diverse perspectives on adoption barriers, stewardship practices, and strategic responses to trade dynamics. Secondary research encompassed regulatory agency communications, industry association statements, and widely accepted scientific syntheses to contextualize primary findings. Analytical frameworks applied in the study include value chain mapping, stakeholder analysis, and scenario-based impact assessment to explore how variables such as tariff shifts and regional regulatory divergence influence strategic choices.

Throughout the research process, attention was paid to methodological transparency and to documenting assumptions that underpin qualitative inferences. Where uncertainty persists, the analysis highlights contingency considerations and recommends targeted follow-up studies to refine understanding in rapidly evolving areas such as gene-editing policy and cross-border germplasm flows.

Concluding synthesis on aligning scientific innovation regulatory compliance stewardship and stakeholder engagement to realize the potential of transgenic crops responsibly

In summary, transgenic crop technologies stand at a strategic inflection point where scientific capability, regulatory evolution, and commercial imperatives converge. The path forward requires integrated strategies that link trait innovation to crop-specific realities, application demands, and end-user expectations. While technological progress lowers technical barriers to developing valuable traits, heterogeneity in regulatory regimes and recent trade policy shifts complicate the operational landscape and necessitate adaptive commercialization roadmaps.

Organizations that succeed will combine scientific excellence with pragmatic regulatory planning, resilient supply chain design, and transparent stewardship. Cross-sector collaboration remains essential for addressing societal concerns, accelerating adaptive breeding in response to climate pressures, and ensuring that benefits reach diverse farming systems. Ultimately, the responsible advancement of transgenic crops hinges on aligning innovation with clear agronomic value, regulatory compliance, and stakeholder trust, thereby enabling these technologies to contribute meaningfully to sustainable agricultural outcomes.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Agricultural Biotechnology for Transgenic Crops Market, by Trait Type

  • 8.1. Drought Tolerance
  • 8.2. Herbicide Tolerance
  • 8.3. Insect Resistance

9. Agricultural Biotechnology for Transgenic Crops Market, by Crop Type

  • 9.1. Canola
  • 9.2. Cotton
  • 9.3. Maize
  • 9.4. Soybean

10. Agricultural Biotechnology for Transgenic Crops Market, by Application

  • 10.1. Biofuel
  • 10.2. Food & Feed
  • 10.3. Pharmaceutical
  • 10.4. Processing

11. Agricultural Biotechnology for Transgenic Crops Market, by End User

  • 11.1. Biotech Companies
  • 11.2. Farmers
  • 11.3. Government Bodies
  • 11.4. Research Institutions
  • 11.5. Seed Companies

12. Agricultural Biotechnology for Transgenic Crops Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Agricultural Biotechnology for Transgenic Crops Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Agricultural Biotechnology for Transgenic Crops Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Agricultural Biotechnology for Transgenic Crops Market

16. China Agricultural Biotechnology for Transgenic Crops Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Arcadia Biosciences, Inc.
  • 17.6. BASF SE
  • 17.7. Bayer AG
  • 17.8. Bioceres Crop Solutions Corp
  • 17.9. Calyxt Inc.
  • 17.10. Corteva, Inc.
  • 17.11. Evogene Ltd
  • 17.12. Groupe Limagrain
  • 17.13. J.R. Simplot Co.
  • 17.14. JK Agri Genetics Ltd.
  • 17.15. KWS SAAT SE & Co. KGaA
  • 17.16. Land O'Lakes, Inc.
  • 17.17. Maharashtra Hybrid Seed Company
  • 17.18. Nuseed Pty Ltd
  • 17.19. Sakata Seed Corporation
  • 17.20. Syngenta AG
  • 17.21. UPL Limited

LIST OF FIGURES

  • FIGURE 1. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY TRAIT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY CROP TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY TRAIT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY DROUGHT TOLERANCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY DROUGHT TOLERANCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY DROUGHT TOLERANCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY HERBICIDE TOLERANCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY HERBICIDE TOLERANCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY HERBICIDE TOLERANCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY INSECT RESISTANCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY INSECT RESISTANCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY INSECT RESISTANCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY CANOLA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY CANOLA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY CANOLA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY COTTON, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY COTTON, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY COTTON, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY MAIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY MAIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY MAIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY SOYBEAN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY SOYBEAN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY SOYBEAN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY BIOFUEL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY BIOFUEL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY BIOFUEL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY FOOD & FEED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY FOOD & FEED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY FOOD & FEED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY PHARMACEUTICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY PHARMACEUTICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY PHARMACEUTICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY PROCESSING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY PROCESSING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY PROCESSING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY BIOTECH COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY BIOTECH COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY BIOTECH COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY FARMERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY FARMERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY FARMERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY GOVERNMENT BODIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY GOVERNMENT BODIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY GOVERNMENT BODIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY RESEARCH INSTITUTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY RESEARCH INSTITUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY SEED COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY SEED COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY SEED COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. AMERICAS AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 56. AMERICAS AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY TRAIT TYPE, 2018-2032 (USD MILLION)
  • TABLE 57. AMERICAS AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 58. AMERICAS AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 59. AMERICAS AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 60. NORTH AMERICA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. NORTH AMERICA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY TRAIT TYPE, 2018-2032 (USD MILLION)
  • TABLE 62. NORTH AMERICA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 63. NORTH AMERICA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 64. NORTH AMERICA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 65. LATIN AMERICA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. LATIN AMERICA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY TRAIT TYPE, 2018-2032 (USD MILLION)
  • TABLE 67. LATIN AMERICA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 68. LATIN AMERICA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 69. LATIN AMERICA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 70. EUROPE, MIDDLE EAST & AFRICA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 71. EUROPE, MIDDLE EAST & AFRICA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY TRAIT TYPE, 2018-2032 (USD MILLION)
  • TABLE 72. EUROPE, MIDDLE EAST & AFRICA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 73. EUROPE, MIDDLE EAST & AFRICA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 74. EUROPE, MIDDLE EAST & AFRICA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 75. EUROPE AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. EUROPE AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY TRAIT TYPE, 2018-2032 (USD MILLION)
  • TABLE 77. EUROPE AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 78. EUROPE AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 79. EUROPE AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 80. MIDDLE EAST AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. MIDDLE EAST AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY TRAIT TYPE, 2018-2032 (USD MILLION)
  • TABLE 82. MIDDLE EAST AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 83. MIDDLE EAST AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 84. MIDDLE EAST AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 85. AFRICA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. AFRICA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY TRAIT TYPE, 2018-2032 (USD MILLION)
  • TABLE 87. AFRICA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 88. AFRICA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 89. AFRICA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 90. ASIA-PACIFIC AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. ASIA-PACIFIC AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY TRAIT TYPE, 2018-2032 (USD MILLION)
  • TABLE 92. ASIA-PACIFIC AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. ASEAN AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. ASEAN AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY TRAIT TYPE, 2018-2032 (USD MILLION)
  • TABLE 98. ASEAN AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 99. ASEAN AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 100. ASEAN AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 101. GCC AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GCC AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY TRAIT TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. GCC AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. GCC AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 105. GCC AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPEAN UNION AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPEAN UNION AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY TRAIT TYPE, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPEAN UNION AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPEAN UNION AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPEAN UNION AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 111. BRICS AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. BRICS AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY TRAIT TYPE, 2018-2032 (USD MILLION)
  • TABLE 113. BRICS AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 114. BRICS AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 115. BRICS AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 116. G7 AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. G7 AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY TRAIT TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. G7 AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. G7 AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 120. G7 AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 121. NATO AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. NATO AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY TRAIT TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. NATO AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 124. NATO AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 125. NATO AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. UNITED STATES AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 128. UNITED STATES AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY TRAIT TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. UNITED STATES AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. UNITED STATES AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 131. UNITED STATES AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 132. CHINA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 133. CHINA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY TRAIT TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. CHINA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. CHINA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 136. CHINA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)